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Abstract The neointimal coverage in patients with coro-
nary artery aneurysms (CAA) formation after drug eluting
stent (DES) implantation is not clear. Total of 175 patients
who had been implanted DES were identified. Patients were
divided into the CAA group (n = 31) and non-CAA group
(n = 144) based on the results of the coronary angiography.
The cardiac events including angina and acute myocardial
infarction were noted, in addition, the neointimal thickness
and the frequence of strut malapposition and strut uncoverage
were noted. A greater proportion of incomplete neointimal
coverage (17.17 vs. 1.9 %, P \ 0.001) and malapposition
struts (18.2 vs. 1.38%, P \ 0.001) were observed in the CAA
group. 8 patients in CAA group underwent OCT examination
twice in the period of follow-up. The proportion of incomplete
neointimal coverage increased significantly as compared the
second OCT results with the first examination (18.45 vs.
2.66 %, P \ 0.001). Hyperplasia neointimal desquamated
from struts and acquired struts incomplete neointimal cover-
age were detected. Patients with CAA had a higher frequency
of cardiac events including angina pectoris (25.81 vs. 6.25 %,
P = 0.001) and acute myocardial infarction (9.68 vs. 0.13 %,
P = 0.002) and thrombosis (16.13 vs. 0.69 %, P \ 0.001).
The longitudinal length of CAA in cardiac event group was
significantly longer than no cardiac event group (20.0 ± 9.07
vs. 12.05 ± 5.38 mm, P = 0.005). CAA formation after
DES implantation frequently associated with cardiac events
as a result of stent malapposition and incomplete neointimal
coverage. Acquired incomplete neointimal coverage associ-
ated with CAA formation.
Keywords Drug-eluting stent  Coronary artery
aneurysms  Optical coherence tomography
Introduction
Some studies have reported that coronary artery aneurysm
(CAA) occurred in 0.3–6.0 % of patients after stent
implantation [1, 2]. The potential causes were the delayed
endothelialization, inflammatory, antimetabolite effect of
the drug, hypersensitivity reactions to the drug and polymer
[3–5]. Based on the follow-up intravascular ultrasound
(IVUS) examination, CAA formation after DES implanta-
tion could enlarge the external elastic membrane and
increase late stent malapposition [6, 7]. However, IVUS
cannot assess the neointimal coverage after stent implan-
tation because of its limited resolution. Therefore, the
status of neointimal coverage in patients with CAA for-
mation after DES implantation remains to be determined.
Optical coherence tomography (OCT) is a new imaging
modality with a higher resolution, approximately tenfold
better than that of the IVUS image. OCT can assess vessel
healing more clearly and accurately during the follow-up of
DES compared with IVUS [8, 9]. The current study aims to




From June 2008 to August 2011, follow-up examinations
were conducted on 1,160 patients who underwent percu-
taneous coronary intervention (PCI). The average period of
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follow-up was approximately (18.9 ± 13.1) months after
PCI. CAA at the segment of stent implantation occurred in
56 patients. Total of 31 patients with CAA formation
underwent OCT examination during follow-up. We labeled
those 31 patients as CAA group (n = 31), and randomly
chose 144 patients who underwent DES implantation into
de novo lesions and underwent coronary angiography and
OCT examination during follow-up without CAA forma-
tion . Those 144 patients were labled as non-CAA group
(n = 144). The exclusion criteria included congestive heart
failure, renal insufficiency (serum creatinine [ 1.8 mg/dL),
left main disease, target vessel diameter C4.0 mm, and
history of revascularization. All patients provided written
informed consent prior to coronary angiography and OCT
examination.
Coronary angiography and PCI
Coronary angiography was performed using a 6 French
catheter through the femoral or radial artery. Heparin
(100 U/Kg) was administered conventionally, and imaging
was performed after administering 200 lg of intracoronary
nitroglycerin. PCI was performed in a standard manner, and
the lesion was completely covered by stents. The types of DES
implantation included the Cypher stent (sirolimus-eluting
stent, Cordis, USA), Endeavor stent (Zotarolimus-eluting
stent, Medtronic, USA), Firebird stent (sirolimus-eluting
stent, Microport, China), Partner stent (sirolimus-eluting
stent, Lepu, China), and Excel stent (sirolimus-eluting stent,
JW, China). The stents were successfully implanted without
complication, and all patients were prescribed with oral
aspirin (100 mg/d) in life and clopidogrel (75 mg/d) for at
least 1 year. The patients underwent coronary angiography
examination in the period of follow-up. Coronary angiograms
(including baseline, intervention and follow-up) were ana-
lyzed by two doctors in the angiographic core laboratory who
were blind to the research. QCA was performed with an
automatic edge-detection system (MEDIS, CMS 4.0, Leiden,
the Netherlands). CAA was defined as a localized angio-
graphic dilation of the vessel lumen (50 % larger than the
adjacent reference vessel) at late angiography, closely related
to the underlying DES or its edges [2, 10].
OCT imaging acquisition and analysis
An M3/C7 OCT system (LightLab Imaging, USA) with an
automatic pullback speed of 1.5 mm/s was used in the
current study. The images included the entire length of the
stent and a segment of at least 5 mm extending beyond the
stent edges. The OCT images were analyzed off-line by
two independent doctors blind to the research. LightLab
Imaging Inc. provided the software. A single OCT cross-
sectional still frame from each 1 mm segment was selected
for quantitative analysis throughout the entire length of the
stent. The still frames were selected based on the appear-
ance of the stent struts and the lack of OCT motion or other
image artifacts. Each stent strut in the still frame was
observed to determine if the strut was a malapposition or a
complete coverage. If a neointimal coverage on the strut
was observed, its average thickness was measured. The
presence of strut malapposition and gaps between the
vessel wall and strut, as well as strut uncoverage, neointi-
mal thickness, stent area, corresponding vessel lumen area
and thrombosis were noted.
Definition of malapposition, neointimal coverage
and thrombosis
Malapposition is defined as the separation of at least one
stent strut from the intimal surface of the arterial wall not
overlapping a side branch, and the gap between the strut
and the vessel wall should exceed 150 lm [11, 12].
Complete neointimal coverage is defined as all the stent
struts were covered by the visible neointimal, strut unco-
verage is confirmed if no visible neointimal coverage on
the strut. Thrombosis is defined as an irregular mass with
dorsal shadowing protruding from the lumen [13].
Statistical analysis
Continuous variables are expressed as the mean ± stan-
dard deviation (SD) and are compared using an indepen-
dent samples t test. Categorical variables are the absolute
number and percentage and are compared using v2 statis-
tics or the Fisher’s exact test. A P value \ 0.05 was con-
sidered statistically significant. Statistical evaluation was
performed using a dedicated software (SPSS 11.5 for
windows, SPSS, Chicago, IL, USA).
Results
Follow-up coronary angiography was conducted on 1,160
patients who had undergone PCI, there were 56 patients
occurred CAA formation at the segment of stent implantation
in the period of follow-up, the ratio of CAA was 4.83 % (56/
1160). Patients with CAA formation after DES implantation
had a higher frequency of cardiac events, total of 40 patients
occurred angina pectoris or acute myocardial infarction,the
frequency of cardiac events was 71.43 % (40/56). OCT was
performed in 175 patients, Table 1 shows the baseline char-
acteristics of CAA group and non-CAA group. The demo-
graphic baseline and coronary risk factors indicates are similar
between two groups except that the number of smoking
patients in the CAA group is higher than that in the non-CAA
group (74.19 vs. 49.92 %, P = 0.008). The period of follow-
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up was longer in the CAA group compared with the non-CAA
group (24.68 ± 13.29 vs. 17.72 ± 12.71 m, P = 0.007). The
cardiac events were frequently occurred in CAA group, there
were 21 patients (10 in the non-CAA group and 11 in the CAA
group) occurred angina pectoris (25.81 vs. 6.25 %,
P = 0.001) and acute myocardial infarction (9.68 vs. 0.13 %,
P = 0.002) during follow-up, in addition, more thrombosis
were detected in CAA group (0.69 vs. 16.13 %, P \ 0.001).
OCT examination was fulfilled after coronary angiography
without complication. OCT readily detected irregular vessel
lumen and malapposition with a prominent cavum backside
the stent struts (Fig. 1d). The optical coherence tomography
results (Table 2) indicate a higher proportion of uncoverage
(17.17 vs. 1.9 %, P \ 0.001) and malapposition struts (18.2
vs. 1.38 %, P \ 0.001) in the CAA group compared with the
non-CAA group. In addition, the neointimal thickness in the
CAA group is significantly thinner than non-CAA group
(146.6 ± 94.8 vs. 192.5 ± 97.1 lm, P \ 0.001), as detected
by OCT. Patients with cardiac events is also analyzed as a
subgroup. Table 3 shows the results of cardiac events in CAA
subgroup. The longitudinal length of CAA in event group is
significantly longer than in no event group (20.0 ± 9.07 vs.
12.05 ± 5.38 mm, P = 0.005). The percentage of stent
malapposition (25.69 ± 19.01 vs. 12.77 ± 7.36 %, P =
0.003) and incomplete neointimal coverage (20.82 ± 17.39
vs. 12.43 ± 8.24 %, P = 0.027) in the group with cardiac
events is significantly higher than in the no cardiac events
group. There were 8 patients with cardiac events in CAA
group underwent OCT examination twice in the period of
follow-up. Total of 1,577 struts were detected and compared
between the first and second OCT results. The proportion of
incomplete neointimal coverage increased significantly as
Table 1 Baseline
characteristics
non-CAA group CAA group P value
Patients (n) 144 31 –
Age (years) 60.44 ± 10.20 60.39 ± 12.02 0.978
Proportion of man (n, %) 115 (79.86) 23 (74.19) 0.483
Diabetes mellitus (n, %) 55 (38.19) 6 (19.35) 0.046
Hypertension (n, %) 97 (67.36) 21 (67.74) 0.967
Hypercholesterolemia (n, %) 39 (27.08) 7 (22.58) 0.605
Smoking (n, %) 69 (49.92) 23 (74.19) 0.008
Systolic blood pressure (mmHg) 129.73 ± 16.91 127.35 ± 18.33 0.486
Diastolic blood pressure (mmHg) 75.74 ± 10.62 75.29 ± 11.11 0.831
Blood glucose (mmol/L) 6.51 ± 2.19 5.44 ± 1.32 0.140
CHO (mmol/L) 3.85 ± 0.95 3.91 ± 0.49 0.867
HDL-C (mmol/L) 1.1 ± 0.26 1.1 ± 0.17 0.994
LDL-C (mmol/L) 2.19 ± 0.87 2.16 ± 0.49 0.802
TG (mmol/L) 1.83 ± 1.42 1.39 ± 0.49 0.346
Target vessel 167 33 –
RCA (n, %) 47 (28.1) 7 (21.2) 0.412
LAD (n, %) 81 (48.5) 23 (69.7) 0.026
LCX (n, %) 39 (23.4) 3 (9.1) 0.066
Stent number (n) 1.35 ± 0.56 1.52 ± 0.67 0.162
Stent diameter (mm) 3.11 ± 0.39 3.06 ± 0.31 0.509
Stent length (mm) 33.32 ± 15.54 38.81 ± 18.85 0.088
Stent types
Cypher/Cypher select (n, %) 39 (27.08) 12 (38.71) 0.196
Endeavor (n, %) 25 (17.37) 3 (9.68) 0.29
Partner (n, %) 21 (14.58) 3 (9.68) 0.437
Firebird (n, %) 26 (18.05) 10 (32.25) 0.076
Excel (n, %) 33 (22.92) 3 (9.68) 0.098
Diagnosis in follow-up
Angina pectoris (n, %) 9 (6.25) 8 (25.81) 0.001
Acute myocardial infarction (n, %) 1 (0.69) 3 (9.68) 0.002
Thrombosis (n, %) 1 (0.69) 5 (16.13) \0.001
Duration between 1st and 2nd angiography (months) 17.72 ± 12.71 24.68 ± 13.29 0.007
Int J Cardiovasc Imaging (2013) 29:1677–1683 1679
123
compared the second OCT results with the first examination
(18.45 vs. 2.66 %, P \ 0.001). The hyperplasia neointimal
desquamated from struts and acquired struts incomplete ne-
ointimal coverage were detected, just as Fig. 1 showed.
A. LAD coronary angiography without aneurysm
B. OCT imaging showed stent complete neointimal
coverage and well apposition
C. LAD coronary angiography with aneurysm formation
D. OCT imaging showed stent incomplete neointimal
coverage(white arrow) and malapposition with cavum
behind struts (yellow arrow). The bare struts had been
completely coveraged by hyperplasia neointimal, as
Fig. 1b showed.
Discussion
The main findings of the current analysis are as follows: (1)
CAA formation after DES implantation increases the fre-
quency of stent malapposition and incomplete neointimal
coverage,acquired incomplete neointimal coverage associ-
ated with CAA formation. (2) CAA was associated with
cardiac events including angina pectoris and acute myocardial
infarction.
Owing to the varying clinical presentations, CAA are
usually detected at the time of repeat angiography for
recurrent symptoms or the routine angiographic follow-up
according to the clinical research protocols. IVUS not only
readily detects the stent malapposition with a prominent
distance between the struts and the vessel wall but also
measures the external elastic lamina area and volume.
According to the IVUS research, CAA are frequently
associated with adverse clinical events as a result of DES
restenosis and thrombosis [6]. However, the neointimal
coverage was not assessed in IVUS clinical trials because
IVUS could not clearly and accurately detect neointimal
coverage. Owing to the greater spatial resolution, OCT
could assess the neointimal coverage and apposition
accurately after DES implantation, and stent apposition and
neointimal coverage may be a useful surrogate parameter
Fig. 1 A patient with coronary
aneurysm formation
Table 2 Optical coherence tomography analysis
non-CAA
group
CAA group P value
Patients (n) 144 31 –
Total stent struts (n) 20969 5375 –
Uncovered stent struts (n,
%)
399 (1.90) 923 (17.17) \0.001
Stent struts malapposition
(n, %)
289 (1.38) 978 (18.20) \0.001
Neointimal thickness (lm) 192.5 ± 97.1 146.6 ± 94.8 \0.001
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for late stent thrombosis and stent safety [14, 15]. OCT
studies have reported that DES implantation for ST ele-
vation myocardial infarction had a higher frequency of
stent malapposition and incomplete neointimal coverage
during follow-up [16, 17], but lacking of datum from CAA
formation after DES implantation. In the current study, the
stent malapposition and neointimal coverage in patients
with CAA formation were assessed using OCT, and a
higher proportion of struts incomplete neointimal coverage
and malapposition was found. Struts incomplete neointimal
coverage and malapposition indicates the poor vessel
healing after DES implantation and as the high fisk of stent
thrombosis [18]. In the research, we found stent incomplete
neointimal coverage and malapposition at the segment of
CAA formation, however, it was complete neointimal
coverage and well apposition before CAA formation as
OCT detected at first time. The procedure of aneurysms
formation usually goes with a tension to stent struts and its
hyperplasia intima, therefore, the hyperplasia neointimal
desquamated from stent struts and the stent struts was bare
again. Maybe this was a new mechanism of incomplete
neointimal coverage in patients with CAA formation, but
further research should be done to prove it.
Moreover, the neointimal thickness is significantly thin
in patients with CAA formation. The potential mechanism
is that the neointimal hyperplasia was depressed when the
stent struts does not come into contact with the vessel
wall. Clinical trials have indicated that stent malapposi-
tion and incomplete coverage are associated with late
stent thrombosis [19, 20]. In our study, a higher number
of patients with stent malapposition and incomplete neo-
intimal coverage in the CAA group had acute myocardial
infarction or angina pectoris compared with the non-CAA
group. This result shows that CAA formation after DES
implantation increases the cardiac events in the long-term
of follow-up.
An additional phenomenon that has been observed in
patients with CAA formation is the irregular vessel lumen
with cavum backside the stent struts. The vessel remodel-
ing can lead to the changement of hydromechanics and
create blood whirlpool in the cavum at the segment of
CAA. This is also a risk factor of stent thrombosis. We also
find that cardiac events readily occurred in the patients with
the longer longitude of CAA. It indicates the more diffused
CAA formation the more risk of cardiac events. The
average time between the first and second coronary angi-
ography in CAA group is (24.68 ± 13.29) months, most
patients undertook single Asprin to antiplatelet therapy
before CAA was diagnosed because dual antiplatelet
therapy was modified after 1 year duration. Notwithstand-
ing some patients with CAA formation without clinical
symptoms, they still belong to the high-risk group of car-
diac events. Therefore, lifelong dual antiplatelet therapy
such as aspirin and clopidogrel, is necessary for those
patients in order to reduce the risk of stent thrombosis.
However, there is no consensus regarding the CAA treat-
ment, further study is needed to assess the strategy.
The mechanism of CAA is still unclear even though
previous reports described local hypersensitivity and
chronic inflammation [3, 4]. The polymer carrier of DES
also induced the inflammatory reaction of the arterial wall
[21]. CAA formation is a slowly Pathophysiologic proce-
dure, it is important to detect CAA at early stage. Late
positive remodeling after stent implantation had been
assessed by IVUS and late stent malapposition was also
observed frequently, although the relationship between
CAA and late stent malapposition remains to be deter-
mined. Hong et al. [22] reported that the predictors of late
stent malapposition include the total stent length, primary
stenting in acute myocardial infarction, and chronic total
occlusion lesions; however, all factors are correlated with
the characteristics of lesion and PCI. Smoking has been
proven a risk factor for cardiovascular disease and is
associated with restenosis and late thrombosis [23, 24].
Smoking can induce an endothelium function disorder as
well as chronic inflammation around the stent, and the
Table 3 Cardiac events in CAA subgroup
Clinical Outcome Event No event P value
Patients (n) 11 20 –
Age (years) 62.45 ± 8.55 56.75 ± 10.18 0.126
Duration between 1st and 2nd angiography (months) 22.64 ± 13.90 25.80 ± 13.17 0.535
Aspirin treatment (n, %) 11 (100) 20 (100) –
Aspirin and clopidogrel (n, %) 3 (27.27) 7 (35) 0.66
Stent length (mm) 45.09 ± 16.71 35.35 ± 19.47 0.173
Stent diameter (mm) 3.21 ± 0.27 2.98 ± 0.31 0.05
Longitudinal length of CAA (mm) 20.0 ± 9.07 12.05 ± 5.38 0.005
Incomplete neointimal coverage (%) 20.82 ± 17.39 12.43 ± 8.24 0.027
Stent malapposition (%) 25.69 ± 19.01 12.77 ± 7.36 0.003
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vessel wall responded to the pathological procedure. The
result also indicates the importance of smoking cessation in
patients who underwent DES implantation.
Limitations
The current study has several limitations. First, it is a
single-center study that involved a small sample. A study
involving larger patient populations from various centers is
warranted to confirm the results. Second, the limited pen-
etration of the current OCT cannot accurately detect the
components of deep structures, especially the external
elastic membrane of the vessel, hence the whole profile of
the cavum backside stent is not clear. In addition, OCT
cannot detect a very thin intimal coverage (\10 lm)
although it was the highest resolution technique at the
present time. This maybe increase the frequency of
uncovered stent struts during OCT imaging analysis.
Conclusions
CAA formation after DES implantation frequently associ-
ated with cardiac events as a result of stent malapposition
and incomplete neointimal coverage. Acquired incomplete
neointimal coverage associated with CAA formation.
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